Alpine Global Management, LLC Adamis Pharmaceuticals Corp Transaction History

Alpine Global Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$2.02 - $3.22 $27,558 - $43,930	-13,643 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.1 - $3.21 $28,650 - $43,794	13,643 New	13,643 $31,000
Q1 2018 May 16, 2018	SELL	$2.55 - $4.85 $58,876 - $111,981	-23,089 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.5 - $5.65 $80,811 - $130,452	23,089	23,089 $102,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.